investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Mechanism of action and therapeutic utility of stimulatory CpG oligonucleotides 

Dennis Klinman

8 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Imtiaz Mawji

Bioensemble, LTD

Mississuaga, Canada

Related projects

Alexander Wlodawer

Protein Structure

All cancers but non-melanoma skin cancer

Alexander Gimelbrant

(PQD4) Epigenetic loss of heterozygosity as a driver of the cancer field effect

All cancers but non-melanoma skin cancer

Marc Nicklaus

Synthetically Accessible Virtual Inventory (SAVI)

All cancers but non-melanoma skin cancer

Israel David Goldman

Core Support for Cancer Center

All cancers but non-melanoma skin cancer

Stefan Taubert

CRC Tier 2 - Studying Mediator Components

All cancers but non-melanoma skin cancer

Arvind Subramaniam

Role of Synonymous Codons as Gene Regulators in Bacteria and Cancer Cells

All cancers but non-melanoma skin cancer

Wei-Shau Hu

Elucidating the Mechanisms of Reverse Transcription and Recombination

All cancers but non-melanoma skin cancer

Sarah Hughes

A Genetic Model for Neurofibromatosis Type II

All cancers but non-melanoma skin cancer

William Muller

Assess the relative contribution of particular signaling molecules to each stage of breast cancer progression (CANADA RESEARCH CHAIRHOLDER)

All cancers but non-melanoma skin cancer